Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994-96

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 4, 1998, Pages 345-349

  Georgopoulos, Apostolos ^a   Buxbaum, Astrid ^a   Straschil, Ursula ^a   Graninger, Wolfgang ^a   Hirschl, A ^b   Wolf, D ^b   Ulrich, W ^b   Setinek Liszka, U ^b   Moser, C ^b   Straschil, U ^b   Bibus, B ^b   Allerberger, F ^b   Sixl, B ^b   Thiel, W ^b   Muller M ^b   Grund, E ^b   Alpi, G ^b   Leitner, G ^b   Pflanzl, W ^b   Aichinger, W ^b   Feichtinger, J ^b   Gogl, H ^b   Brinninger, G ^b   Ohlinger W ^b   Gerstner, L ^b   Hudler, H ^b   Drlicek, M ^b   Bankl, H ^b   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b General Hospital of Vienna ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFADROXIL; CEFODIZIME; CEFOTAXIME; CEFPIROME; CEFPODOXIME; CEFTRIAXONE; CLARITHROMYCIN; JOSAMYCIN; MACROLIDE; PENICILLIN G; ROXITHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRIA; HUMAN; LABORATORY; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; AUSTRIA; BETA-LACTAM RESISTANCE; DRUG RESISTANCE, MICROBIAL; HUMANS; LACTAMS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; STREPTOCOCCUS PNEUMONIAE;

EID: 7844249788     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850160611     Document Type: Article

References (37)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
2. Spangler SK, Jacobs MR, Pankuch GA, Appelbaum PC. Susceptibility of 170 penicilin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. J Antimicrob Chemother 1997; 31: 273-80.
3. Appelbaum PC. Emerging resistance to antimicrobial agents in gram-positive bacteria. Drugs 1996; 51 (Suppl 1): 1-5.
4. Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15: 99-105.
5. Nava JM, Bella F, Garau J, Lite J, Morera M, Marti C, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19: 884-90.
6. Marton A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991; 163: 542-8.
7. Reichler MR, Rakovsky J, Sobotova A, Slacikova M, Hlavacova B, Hill B, et al. Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. J Infect Dis 1995; 171: 1491-6.
8. Ednie LM, Visalli MA, Jacobs MR, Appelbaum PC. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneuococci. Antimicrob Agents Chemother 1996; 40: 1950-2.
9. Pankuch GA, Jacobs MR, Appelbaum PC. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 1995; 35: 883-8.
10. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS publication no. M100-S5. Villanova PA: National Committee for Clinical Laboratory Standards, 1995.
11. Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992; 15: 119-27.
12. Geslin P, Buu-Hoi A, Fremaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France 1970-1990. Clin Infect Dis 1992; 15: 95-8.
13. Goldstein FW, Geslin P, Acar JF. the French Study Group. Comparative activity of teicoplanin and vancomycin against 400 penicillin-susceptible and -resistant Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 1994; 13: 33-4.
14. Gür D, Tunckanat F, Sener B, Kanra G, Akalin HE. Penicillin resistance in Streptococcus pneumoniae in Turkey. Eur J Clin Microbiol Infect Dis 1994; 13: 440-1.
15. Kanavaki S, Karabela S, Marinis E, Legakis NJ. Antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Greece. Antimicrob Agents Chemother 1994; 32: 3056-8.
16. Linares J, Alonso T, Perez JL, Ayats J, Dominguez MA, Pallares R. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob Chemother 1992; 30: 279-88.
17. Halls GA, The management of infections and antibiotic therapy: an European survey. J Antimicrob Chemother 1993; 31: 985-1000.
18. Marchese A, Debbia EA, Arvigo A, Pesce A, Schito GC. Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics. J Antimicrob Chemother 1995; 36: 833-7.
19. Wüst J, Huf E, Kayser FH. Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland. J Clin Microbiol 1995; 33: 3159-63.
20. Gross ME, Giron KP, Septimus JD, Mason EO, Musher DM. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother 1995; 39: 1166-8.
21. Simor AE, Louie M. The Canadian Bacterial Surveillance Network, Low DE.: Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40: 2190-3.
22. Spangler SK, Jacobs MR, Appelbaum PC. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents. Antimicrob Agents Chemother 1997; 41: 148-55.
23. Breimann RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococci infections in the United States. J Amer Med Assoc 1994; 271: 1831-5.
24. Ednie LM, Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrob Agents Chemother 1997; 41: 1033-6.
25. Garcia-Leoni ME, Cercenadi E, Rodeno P, Bernaldo-de-Quiros JC, Martinez-Hernandez D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992; 14: 427-35.
26. Reinen RR, Queck A, Kaufhold A, Kresken M, Lütticken R. Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany 1992-1994. Clin Infect Dis 1995; 21: 1398-401.
27. Linares J, Alonso T, Ayats J, Alcaide F, Tubau F, Hernandez J, Martin R. In vitro activity of 7 macrolide antibiotics and 9 other antimicrobial agents against penicillin-resistant pneumococci. abstr. 191. p. 130. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1991.
28. Mason EO, Kaplan SL, Lamberth LB, Tillman J. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother 1992; 36: 1703-7.
29. Nelson CT, Mason EO, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Ped Infect Dis J 1994; 13: 585-9.
30. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New Engl J Med 1994; 331: 377-82.
31. Traub WH, Leonhard B. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae. Chemother 1996; 42: 240-7.
32. Paris MM, Ramilo O, McCracken GH. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemotherapy 1995; 39: 2171-5.
33. Viladrich PF, Gudiol F, Linares J, Pallares R, Sabate I, Rufi G, Ariza J. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991; 35: 2467-72.
34. Viladrich PF, Cabellos C, Pallares R, Tubau F, Martinez-Lacasa J, Linares J, Gudiol F. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 218-20.
35. Hofmann J, Cetron MS, Farley MM, Braughman WS, Facklam RR, Elliott JA, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. New Engl J Med 1995; 333: 481-6.
36. Kiska DL, Kerr A, Jones MC, Chazotte NN, Eskridge B, Miller S, et al. Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1995; 33: 229-32.
37. Moreillon P, Tomasz A. Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment. J Infect Dis 1988; 157: 1150-7.